North America Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, Human) by Indication (Cancer, Autoimmune diseases, infectious diseases, Cardiovascular diseases, CNS disorders, others) by End-User (Hospitals/Clinics, Research Institute, Diagnostic Laboratories) by Application (Medical, Experimental) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
- Advertising -
According to the report on North America Monoclonal Antibodies Market, published by Market Data Forecast, the market is projected to reach USD 49.2 Billion by 2021, at a CAGR of 6.24% from 2016 to 2021.
Monoclonal antibodies are created in the laboratory instead of using human’s own immune system. The anti-bodies may later on combine with other parts of the human immune system for the destruction of an antigen, such as a cancer cell.
Clinical trials of monoclonal antibody treatment are carried out on almost every type of cancer.
- Advertising -
Monoclonal antibodies are more effective than several other options to treat autoimmune diseases and hence are becoming popular.
Get a comprehensive overview of the North America Monoclonal Antibodies Market: www.marketdataforecast.com/market-…s-market-1185/%20
North America Monoclonal Antibodies Market: Drivers & Restraints
North America Monoclonal Antibodies market is majorly fuelled by high rates of product sanctioning, combined with increasing trends of adaptation of both diagnostic and therapeutic antibodies. Growing amount of R & D activities is also a major driving force that propels the growth of this market.
Patients and also the general public is becoming more and more aware about various applications of mAb and this is also a a key factor adding to the market growth. However, the high costs required in their development is the major factor restraining the growth of the market.
Get accurate market forecast and analysis on the North America Monoclonal Antibodies Market. Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-…85/request-sample
North America Monoclonal Antibodies Market: Segmentation
By Source Market
o Blood Cancer
o Breast Cancer
o Colorectal Cancer
o Lung Cancer
o Pancreatic Cancer
- Auto Immune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- CNS Disorders
By End User
- Research Institute
- Diagnostic Laboratories
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information. Get report at www.marketdataforecast.com/market-…/customize-report
North America Monoclonal Antibodies Market: Overview
The North America Antibodies Market was worth USD 36.3 billion as of 2016 and is expected to show significant potential in the mentioned forecasting period. The Human segment has the leading position in the market on the basis of source. In the past few years, the extent of adoption of monoclonal antibodies for treating various diseases that are associated with immune response has shown a significant rise.
Thus, North America Monoclonal Antibodies market is expected to show evident potential with the rise in implementation of these anti-bodies.
North America Monoclonal Antibodies Market: Region-wise Outlook
Geographically, North America monoclonal antibodies market is analysed under the two regions United States and Canada. United States is the biggest market for mAb`s whereas Canada is expected to grow at the fastest pace due to increasing awareness regarding the antibody products.
Key Questions Answered
- What is the current and future North America Monoclonal Antibodies Market outlook? What trends are affecting the market?
- What is the competitive landscape and market share of major players in the North America Monoclonal Antibodies Market?
- What are the key market segments that currently occupy the highest market share? Which market segments are growing the fastest?
- What challenges are restraining the growth of the North America Monoclonal Antibodies Market? How will emerging technologies answer these challenges?
North America Monoclonal Antibodies Market: Key Players
The key players in the North America Monoclonal Antibodies market are GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland) and Biogen Inc.(U.S.).
Reasons to access North America Monoclonal Antibodies Market Report:
- Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
- Segment-level analysis on basis of source market, application and end-user with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
- A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: